Announced Wed, 24 Jun · 14:58 IST
Trading Window Closure - Quarter Ended June 30, 2026
Compliance View source PDF
LINCOLN · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+4.0%1-day move
₹605.50
prior close
₹607.20
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.4-0.5-0.2-0.7+4.0+3.6+3.2+3.0+3.7+1.3-0.4-3.9——
Up moveDown movePending
AI summary
Lincoln Pharmaceuticals has informed the stock exchange that the trading window for designated persons and insiders will be closed for the quarter ending June 30, 2026. This is a standard compliance measure under SEBI insider trading regulations, preventing insiders from trading in company shares during the period around financial results declaration.
Likely market impact
Routine regulatory compliance. Insiders cannot trade shares until results are announced. No material impact on stock price expected.